448 related articles for article (PubMed ID: 21076045)
21. LMO2 Oncoprotein Stability in T-Cell Leukemia Requires Direct LDB1 Binding.
Layer JH; Alford CE; McDonald WH; Davé UP
Mol Cell Biol; 2016 Feb; 36(3):488-506. PubMed ID: 26598604
[TBL] [Abstract][Full Text] [Related]
22. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins.
Wadman IA; Osada H; Grütz GG; Agulnick AD; Westphal H; Forster A; Rabbitts TH
EMBO J; 1997 Jun; 16(11):3145-57. PubMed ID: 9214632
[TBL] [Abstract][Full Text] [Related]
23. Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.
Deleuze V; El-Hajj R; Chalhoub E; Dohet C; Pinet V; Couttet P; Mathieu D
PLoS One; 2012; 7(7):e40484. PubMed ID: 22792348
[TBL] [Abstract][Full Text] [Related]
24. Runx genes are direct targets of Scl/Tal1 in the yolk sac and fetal liver.
Landry JR; Kinston S; Knezevic K; de Bruijn MF; Wilson N; Nottingham WT; Peitz M; Edenhofer F; Pimanda JE; Ottersbach K; Göttgens B
Blood; 2008 Mar; 111(6):3005-14. PubMed ID: 18184866
[TBL] [Abstract][Full Text] [Related]
25. The Hematopoietic Stem and Progenitor Cell Cistrome: GATA Factor-Dependent cis-Regulatory Mechanisms.
Hewitt KJ; Johnson KD; Gao X; Keles S; Bresnick EH
Curr Top Dev Biol; 2016; 118():45-76. PubMed ID: 27137654
[TBL] [Abstract][Full Text] [Related]
26. Ldb1 complexes: the new master regulators of erythroid gene transcription.
Love PE; Warzecha C; Li L
Trends Genet; 2014 Jan; 30(1):1-9. PubMed ID: 24290192
[TBL] [Abstract][Full Text] [Related]
27. A positive role for NLI/Ldb1 in long-range beta-globin locus control region function.
Song SH; Hou C; Dean A
Mol Cell; 2007 Dec; 28(5):810-22. PubMed ID: 18082606
[TBL] [Abstract][Full Text] [Related]
28. Tandem LIM domains provide synergistic binding in the LMO4:Ldb1 complex.
Deane JE; Ryan DP; Sunde M; Maher MJ; Guss JM; Visvader JE; Matthews JM
EMBO J; 2004 Sep; 23(18):3589-98. PubMed ID: 15343268
[TBL] [Abstract][Full Text] [Related]
29. Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice.
Larson RC; Lavenir I; Larson TA; Baer R; Warren AJ; Wadman I; Nottage K; Rabbitts TH
EMBO J; 1996 Mar; 15(5):1021-7. PubMed ID: 8605871
[TBL] [Abstract][Full Text] [Related]
30. Different sequence requirements for expression in erythroid and megakaryocytic cells within a regulatory element upstream of the GATA-1 gene.
Vyas P; McDevitt MA; Cantor AB; Katz SG; Fujiwara Y; Orkin SH
Development; 1999 Jun; 126(12):2799-811. PubMed ID: 10331989
[TBL] [Abstract][Full Text] [Related]
31. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
Hoang T; Lambert JA; Martin R
Curr Top Dev Biol; 2016; 118():163-204. PubMed ID: 27137657
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional control of fetal liver hematopoiesis: dominant negative effect of the overexpression of the LIM domain mutants of LMO2.
Terano T; Zhong Y; Toyokuni S; Hiai H; Yamada Y
Exp Hematol; 2005 Jun; 33(6):641-51. PubMed ID: 15911088
[TBL] [Abstract][Full Text] [Related]
33. Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1.
Osada H; Grutz G; Axelson H; Forster A; Rabbitts TH
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9585-9. PubMed ID: 7568177
[TBL] [Abstract][Full Text] [Related]
34. The LIM domain protein Lmo2 binds to AF6, a translocation partner of the MLL oncogene.
Bégay-Müller V; Ansieau S; Leutz A
FEBS Lett; 2002 Jun; 521(1-3):36-8. PubMed ID: 12067721
[TBL] [Abstract][Full Text] [Related]
35. Design, production and characterization of FLIN2 and FLIN4: the engineering of intramolecular ldb1:LMO complexes.
Deane JE; Sum E; Mackay JP; Lindeman GJ; Visvader JE; Matthews JM
Protein Eng; 2001 Jul; 14(7):493-9. PubMed ID: 11522923
[TBL] [Abstract][Full Text] [Related]
36. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.
Tatarek J; Cullion K; Ashworth T; Gerstein R; Aster JC; Kelliher MA
Blood; 2011 Aug; 118(6):1579-90. PubMed ID: 21670468
[TBL] [Abstract][Full Text] [Related]
37. A PAR domain transcription factor is involved in the expression from a hematopoietic-specific promoter for the human LMO2 gene.
Crable SC; Anderson KP
Blood; 2003 Jun; 101(12):4757-64. PubMed ID: 12609830
[TBL] [Abstract][Full Text] [Related]
38. Primitive erythropoiesis in the Xenopus embryo: the synergistic role of LMO-2, SCL and GATA-binding proteins.
Mead PE; Deconinck AE; Huber TL; Orkin SH; Zon LI
Development; 2001 Jun; 128(12):2301-8. PubMed ID: 11493549
[TBL] [Abstract][Full Text] [Related]
39. LMO2 is required for TAL1 DNA binding activity and initiation of definitive haematopoiesis at the haemangioblast stage.
Stanulovic VS; Cauchy P; Assi SA; Hoogenkamp M
Nucleic Acids Res; 2017 Sep; 45(17):9874-9888. PubMed ID: 28973433
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL.
Ono Y; Fukuhara N; Yoshie O
J Biol Chem; 1997 Feb; 272(7):4576-81. PubMed ID: 9020185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
